Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment and <i>RAS</i> Mutations in Colorectal Cancer

Eric Van Cutsem(Universitair Ziekenhuis Leuven), Fortunato Ciardiello(University of Campania "Luigi Vanvitelli")

Journal of Clinical Oncology

January 21, 2015

10.1200/jco.2014.59.4812

Cited by 795

Related Papers

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

|The Lancet|2010|7.3k

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

|New England Journal of Medicine|2013|6.6k

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial

|The Lancet|2016|4.8k

Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors

|New England Journal of Medicine|2017|3.2k

Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer

|New England Journal of Medicine|2019|2.2k